Back
Corporate News
Morepen Laboratories’ revenue reached Rs 755 crore, fueled by CDMO business expansion
27-Oct-2026, 02:14
Morepen Laboratories Limited announced record revenue and earnings for the quarter and half year ended September 30, 2026, driven by the commercial scale-up of its contract development and manufacturing organization (CDMO) business, with revenue reaching Rs 755 crore. The company's H1 export revenue was Rs 654 crore, up 122% year-over-year, now representing approximately 50% of its sales revenue.
